Original issue discount debentures sold by Oppenheimer, JMP Securities
By Devika Patel
Knoxville, Tenn., April 5 - InspireMD, Inc. said it completed a private placement of $11.7 million of original issue discount senior secured convertible debentures, which were sold at a discount for $11 million.
The 8% debentures are convertible into common stock at $1.75 per share and due April 5, 2014. The company may force conversion, and the notes may be put at 112 plus interest after 18 months.
The investors also received 50% warrant coverage. The warrants are each exercisable at $1.80 for five years.
The strike price is a 28.57% premium to the April 4 closing share price of $1.40. The conversion price is a 25% premium to that price.
Oppenheimer & Co. Inc. was the lead agent; JMP Securities LLC was co-lead placement agent.
Proceeds will be used for clinical trials, expanding sales and marketing and general working capital.
InspireMD is a Tel Aviv, Israel, medical device company developing its proprietary stent system technology, MGuard.
| Issuer: | InspireMD, Inc.
|
| Issue: | Original issue discount senior secured convertible debentures
|
| Amount: | $11.7 million
|
| Maturity: | April 5, 2014
|
| Coupon: | 8%
|
| Price: | $11 million
|
| Conversion price: | $1.75
|
| Call: | Yes
|
| Put: | At 112, after 18 months
|
| Warrants: | 50% coverage
|
| Warrant expiration: | Five years
|
| Warrant strike price: | $1.80
|
| Agents: | Oppenheimer & Co. Inc. (lead), JMP Securities LLC (co-lead)
|
| Settlement date: | April 5
|
| Stock symbol: | OTCBB: NSPR
|
| Stock price: | $1.40 at close April 4
|
| Market capitalization: | $98.86 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
